SecBot SecBot
COURT-RULING ·Filed Jul 15, 2026

TEVA

TEVA PHARMACEUTICAL INDUSTRIES LTD
NEUTRAL
Impact 2/10
Horizonmonths Processed4mo ago CourtCourt Ruling · govinfo.gov
Court ruling (district)
Actionable Insight • Neutral

This discovery dispute ruling has no material financial impact on TEVA. The underlying antitrust case against Corcept continues. Monitor for summary judgment motions or trial dates, which could affect the stock if material exposure emerges.

DirectionNeutral
Confidencehigh
Horizonmonths

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$32.22
T+0 close · Jul 16, 2026 · via day close
Latest settled
+27.56%
T+60 · $41.10
Vs SPY
+23.59%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jul 16 $32.22entry
  2. T+1 · 4mo ago −0.59%α +0.40% · $32.03
  3. T+5 · 4mo ago −3.23%α −1.56% · $31.18
  4. T+20 · 3mo ago +13.35%α +9.73% · $36.52
  5. T+60 · 6w ago +27.56%α +23.59% · $41.10
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

A federal magistrate judge partially granted and partially denied Corcept Therapeutics' motion to compel discovery from Teva's CEO Richard Francis. Teva's CEO must sit for a limited two-hour deposition regarding his critique of Teva's generic mifepristone promotion strategies, but Teva is not required to produce his custodial documents. This is a routine procedural discovery ruling in an ongoing antitrust case with no immediate financial impact.

Court Ruling Details

Ruling Date
Jul 15, 2026
Court
United States District Court for the Northern District of California
Court Level
District
Judge
Virginia K. DeMarchi
Case Type
antitrust
Ruling Type
discovery
Outcome
PARTIAL: mixed ruling, some claims won/lost
Precedent Risk
LOW

Key Facts

  • Teva is the plaintiff in an antitrust case against Corcept regarding generic mifepristone for Cushing's syndrome.
  • Corcept sought to depose Teva's CEO Richard Francis and obtain his documents; the court granted a limited 2-hour deposition on one topic and denied document production.
  • The deposition is limited to Mr. Francis's critique of Teva's strategy for promoting generic mifepristone and his ideas for solutions.
  • Fact discovery in the case closed on May 15, 2026.

Financial Impact

None stated. The ruling involves only discovery scope, no monetary award or injunctive relief.

Risk Factors

  • CEO deposition may reveal internal discussions that could weaken Teva's causation argument in the antitrust case.
  • Continued litigation costs and management distraction from the underlying antitrust case.

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 court opinion.

DocumentAccession Number
COURT-RULING Data (Synthetic)court-10e56aaee5-TEVA

Track record

61 reports on TEVA

Performance horizon

6 of 8 bullish or bearish reports moved the stock their way by T+60. Best: +33.06% at T+60 after the Jul 20, 2026 report. 15 of 17 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $43.16 Now $42.57 −1.37% settles Feb 12
  2. Nov 12, 20264d ago 3 Neutral 2/10 Entry $44.50 Now $42.57 −4.34% settles Feb 11
  3. Nov 12, 20264d ago 144 Neutral 2/10 Entry $44.50 Now $42.57 −4.34% settles Feb 11
  4. Nov 12, 20264d ago 144 Neutral 2/10 Entry $43.65 Now $42.57 −2.47% settles Feb 10
  5. Nov 10, 20266d ago 144 Neutral 3/10 Entry $43.24 Now $42.57 −1.55% settles Feb 9
  6. Nov 10, 20266d ago SC 13G/A Neutral 3/10 Entry $42.40 Now $42.57 +0.40% settles Feb 8
  7. Nov 9, 20267d ago 144 Neutral 2/10 Entry $42.40 Now $42.57 +0.40% settles Feb 8
  8. Nov 6, 202610d ago Insider Cluster Neutral 3/10 Entry $42.97 Now $42.57 −0.93% settles Feb 5
  9. Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $42.97 Now $42.57 −0.93% settles Feb 5
  10. Nov 5, 202611d ago 144 Neutral 2/10 Entry $42.61 Now $42.57 −0.09% settles Feb 4
Showing 10 of 61

US Market Status

Market Closed · Opens in 8h 38m

Subscribe to SecBot

Get Real-Time Court Ruling Intelligence

Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more, parsed and scored by AI.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
⚖ Court Ruling · govinfo.gov Report published Jul 16, 2026